Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke [NA]

View source ↗

Summary

This is a prospective, single-arm study evaluating the endothelialization effect and timeline of the AnchorMan Left Atrial Appendage Occluder in non-valvular at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AnchorMan Left Atrial Appendage Occluder

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Non-valvular Atrial Fibrillation (NVAF), High Risk of Stroke | NA | Status: NOT_YET_RECRUITING